Sleep Quality and Pain Medication Use Following Arthroscopic Rotator Cuff Repair

Rothman Institute Orthopaedics80 enrolled

Overview

The purpose of this study is to investigate if oral melatonin reduces postoperative sleep 18 disturbances and narcotics use. We will enroll patients undergoing primary arthroscopic rotator 19 cuff repair (ARCR) at the Rothman Institute.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Sleep Disturbance

Interventions

melatoninDIETARY_SUPPLEMENT

Melatonin capsules to be taken for 6 weeks

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who undergo primary ARCR * Patient willing and able to complete postoperative surveys Exclusion Criteria: * Daily melatonin use for \> 1 week during the last 3 months * Irreparable tears * Revision rotator cuff repairs * Severe glenohumeral arthritis * Concurrent adhesive capsulitis * Age less than 18 * Pregnancy * History of substance abuse (drug or alcohol) * Workman's comp patient or patient has current litigation pending * Allergy to melatonin * History of delirium/psychiatric/depression/ on antidepressants * History of insomnia/ on sleep aid medication * Use of prescription sedatives * use of Zelboraf (vemurafenib) * Use of all blood thinning medications besides aspirin (warfarin, plavix, lovenox, etc.) * Sleep apnea

Locations (1)

Rothman Orthopaedics at Egg Harbor Township

Egg Harbor, New Jersey, United States

Outcomes

Primary Outcomes

Pittsburg Sleep Quality Index (PSQI)

PSQI is a validated outcome measure for sleep quality

Time frame: 6 weeks post-surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.